Pneumonitis
Information
- Disease name
- Pneumonitis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT04590547 | Active, not recruiting | Phase 2 | GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19) | May 7, 2021 | December 2023 |
NCT00997555 | Completed | N/A | Prophylactic Bronchoscopy After Inhalation Injury in Burn Patients | October 2009 | July 2012 |
NCT02246361 | Completed | Phase 4 | Impact of Six Patient Information Leaflets (PIL) on Doctor Patient Communication | September 2014 | May 2015 |
NCT02788643 | Completed | Study of Collagen IV and XIX in Bronchoalveolar Lavage, Pulmonary Aspiration and Bronchial Biopsies | May 2014 | December 2017 | |
NCT03012958 | Completed | Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease | July 2014 | May 2018 | |
NCT03730428 | Completed | Everolimus Related Pneumonitis in MBC | July 15, 2017 | June 15, 2020 | |
NCT00081315 | Completed | Phase 2 | Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer | November 2003 | August 2006 |
NCT04721444 | Completed | Optimising Cancer Therapy And Identifying Causes of Pneumonitis USing Artificial Intelligence (COVID-19) | January 27, 2021 | March 1, 2022 | |
NCT04302688 | Completed | Accurate Classification System for Patients With COVID-19 Pneumonitis | December 10, 2019 | March 4, 2020 | |
NCT05455034 | Recruiting | Phase 1/Phase 2 | Single-cell Sequencing of BLF to Guide the Treatment of Radiation Pneumonitis or Immune Checkpoint Inhibitor Pneumonitis | August 1, 2023 | June 30, 2025 |
NCT05280873 | Recruiting | Phase 1 | Pirfenidone Combined With Methylprednisolone Versus Methylprednisolone in the Treatment of CIP | October 10, 2021 | October 20, 2024 |
NCT04040244 | Terminated | N/A | Exhaled Breath Analysis to Predict Risk of Symptomatic Pneumonitis | December 9, 2019 | March 10, 2022 |
NCT03962725 | Terminated | Phase 4 | Avoiding Neuromuscular Blockers to Reduce Complications | August 7, 2019 | December 19, 2022 |
NCT04370834 | Terminated | Phase 2 | Tocilizumab for Patients With Cancer and COVID-19 Disease | May 28, 2020 | January 14, 2021 |
NCT04326725 | Unknown status | Proflaxis Using Hydroxychloroquine Plus Vitamins-Zinc During COVID-19 Pandemia | March 20, 2020 | September 1, 2020 |